Single domain antibodies: Promising experimental and therapeutic tools in infection and immunity

Medical Microbiology and Immunology

Volumn 198, Issue 3, 2009, Pages 157-174

  Wesolowski, Janusz ^a   Alzogaray, Vanina ^b   Reyelt, Jan ^a   Unger, Mandy ^a   Juarez, Karla ^a,c   Urrutia, Mariela ^b   Cauerhff, Ana ^b   Danquah, Welbeck ^a   Rissiek, Björn ^a   Scheuplein, Felix ^a,d   Schwarz, Nicole ^a   Adriouch, Sahil ^e   Boyer, Olivier ^e   Seman, Michel ^e   Licea, Alexei ^c   Serreze, David V ^d   Goldbaum, Fernando A ^b   Haag, Friedrich ^a   Koch Nolte, Friedrich ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b FUNDACIÓN INSTITUTO LELOIR   (Argentina)

^c CENTRO DE INVESTIGACIÓN CIENTÍFICA Y DE EDUCACIÓN SUPERIOR DE ENSENADA   (Mexico)

^d JACKSON LABORATORY   (United States)

^e ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Enzyme inhibitors; Nanobody; Recombinant antibodies; Single domain antibodies; VHH; Virus neutralization

Indexed keywords

ANTIBODY; BACTERIUM ANTIBODY; BEVACIZUMAB; BISPECIFIC ANTIBODY; CELL SURFACE PROTEIN; CETUXIMAB; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HYBRID PROTEIN; NAT 267; NEUTRALIZING ANTIBODY; OMALIZUMAB; PARASITE ANTIBODY; POLY A BINDING PROTEIN 1 ANTIBODY; PROTEIN BAX ANTIBODY; RECOMBINANT ANTIBODY; RITUXIMAB; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; SINGLE DOMAIN ANTIBODY; TOXIN ANTIBODY; TRASTUZUMAB; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VON WILLEBRAND FACTOR ANTIBODY;

AMINO ACID SEQUENCE; ANTIBODY STRUCTURE; ARTHRITIS; ASTHMA; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BREAST CANCER; CARBOXY TERMINAL SEQUENCE; CLINICAL TRIAL; COLORECTAL CANCER; DRUG EFFECT; DRUG TARGETING; HUMAN; INFECTION; MOLECULAR CLONING; MOLECULAR MIMICRY; NONHUMAN; OCULOPHARYNGEAL MUSCULAR DYSTROPHY; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; RHEUMATOID ARTHRITIS; SEQUENCE ALIGNMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; VIREMIA; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; CAMELIDS, NEW WORLD; COMPLEMENTARITY DETERMINING REGIONS; IMMUNOGLOBULIN HEAVY CHAINS; MOLECULAR CONFORMATION; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; SHARKS;

EID: 68349117269     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-009-0116-7     Document Type: Review

References (128)

1. OH Brekke I Sandlie 2003 Therapeutic antibodies for human diseases at the dawn of the twenty-first century Nat Rev Drug Discov 2 1 52 62 10.1038/nrd984 (Pubitemid 37361624)
2. C Hamers-Casterman T Atarhouch S Muyldermans G Robinson C Hamers EB Songa N Bendahman R Hamers 1993 Naturally occurring antibodies devoid of light chains Nature 363 6428 446 448 10.1038/363446a0 (Pubitemid 23179389)
3. S Muyldermans 2001 Single domain camel antibodies: current status J Biotechnol 74 4 277 302
4. P Holliger PJ Hudson 2005 Engineered antibody fragments and the rise of single domains Nat Biotechnol 23 9 1126 1136 10.1038/nbt1142 (Pubitemid 41486394)
5. A Desmyter TR Transue MA Ghahroudi MH Thi F Poortmans R Hamers S Muyldermans L Wyns 1996 Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme Nat Struct Biol 3 9 803 811 10.1038/nsb0996-803 (Pubitemid 26303407)
6. E De Genst K Silence K Decanniere K Conrath R Loris J Kinne S Muyldermans L Wyns 2006 Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies Proc Natl Acad Sci USA 103 12 4586 4591 10.1073/pnas.0505379103
7. TT Wu G Johnson EA Kabat 1993 Length distribution of CDRH3 in antibodies Proteins 16 1 1 7 10.1002/prot.340160102
8. MM Harmsen HJ De Haard 2007 Properties, production, and applications of camelid single-domain antibody fragments Appl Microbiol Biotechnol 77 1 13 22 10.1007/s00253-007-1142-2 (Pubitemid 47573319)
9. A Pini L Bracci 2000 Phage display of antibody fragments Curr Protein Pept Sci 1 2 155 169 10.2174/1389203003381397
10. HR Hoogenboom 2005 Selecting and screening recombinant antibody libraries Nat Biotechnol 23 9 1105 1116 10.1038/nbt1126 (Pubitemid 41486392)
11. V Cortez-Retamozo M Lauwereys Gh G Hassanzadeh M Gobert K Conrath S Muyldermans P De Baetselier H Revets 2002 Efficient tumor targeting by single-domain antibody fragments of camels Int J Cancer 98 3 456 462 10.1002/ijc.10212 (Pubitemid 34188691)
12. M Dumoulin AM Last A Desmyter K Decanniere D Canet G Larsson A Spencer DB Archer J Sasse S Muyldermans L Wyns C Redfield A Matagne CV Robinson CM Dobson 2003 A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme Nature 424 6950 783 788 10.1038/nature01870 (Pubitemid 37021708)
13. EK Conrath M Lauwereys L Wyns S Muyldermans 2001 Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs J Biol Chem 276 10 7346 7350 10.1074/jbc.M007734200
14. U Rothbauer K Zolghadr S Tillib D Nowak L Schermelleh A Gahl N Backmann K Conrath S Muyldermans MC Cardoso H Leonhardt 2006 Targeting and tracing antigens in live cells with fluorescent nanobodies Nat Methods 3 11 887 889 10.1038/nmeth953 (Pubitemid 44614722)
15. A Olichon T Surrey 2007 Selection of genetically encoded fluorescent single domain antibodies engineered for efficient expression in Escherichia coli J Biol Chem 282 50 36314 36320 10.1074/jbc.M704908200
16. K Coppieters T Dreier K Silence H De Haard M Lauwereys P Casteels E Beirnaert H Jonckheere C Van de Wiele L Staelens J Hostens H Revets E Remaut D Elewaut P Rottiers 2006 Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis Arthritis Rheum 54 6 1856 1866 10.1002/art.21827 (Pubitemid 43877935)
17. N Pant A Hultberg Y Zhao L Svensson Q Pan-Hammarstrom K Johansen PH Pouwels FM Ruggeri P Hermans L Frenken T Boren H Marcotte L Hammarstrom 2006 Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea J Infect Dis 194 11 1580 1588 10.1086/508747
18. D Gueorguieva S Li N Walsh A Mukerji J Tanha S Pandey 2006 Identification of single-domain, Bax-specific intrabodies that confer resistance to mammalian cells against oxidative-stress-induced apoptosis FASEB J 20 14 2636 2638 10.1096/fj.06-6306fje (Pubitemid 44953805)
19. SA Jobling C Jarman MM Teh N Holmberg C Blake ME Verhoeyen 2003 Immunomodulation of enzyme function in plants by single-domain antibody fragments Nat Biotechnol 21 1 77 80 10.1038/nbt772 (Pubitemid 36055831)
20. B Serruys F Van Houtte P Verbrugghe G Leroux-Roels P Vanlandschoot 2009 Llama-derived single-domain intrabodies inhibit secretion of hepatitis B virions in mice Hepatology 49 1 39 49 10.1002/hep.22609
21. M Feldmann 2002 Development of anti-TNF therapy for rheumatoid arthritis Nat Rev Immunol 2 5 364 371 10.1038/nri802
22. N Lonberg 2008 Fully human antibodies from transgenic mouse and phage display platforms Curr Opin Immunol 20 4 450 459 10.1016/j.coi.2008.06.004
23. A Drucker C Skedgel K Virik D Rayson M Sellon T Younis 2008 The cost burden of trastuzumab and bevacizumab therapy for solid tumours in Canada Curr Oncol 15 3 136 142 10.3747/co.v15i3.249
24. JW Goding MC Howard 1998 Ecto-enzymes of lymphoid cells Immunol Rev 161 5 10 10.1111/j.1600-065X.1998.tb01567.x
25. M Salmi S Jalkanen 2005 Cell-surface enzymes in control of leukocyte trafficking Nat Rev Immunol 5 10 760 771 10.1038/nri1705 (Pubitemid 41400850)
26. D Corda M Di Girolamo 2003 Functional aspects of protein mono-ADP-ribosylation EMBO J 22 9 1953 1958 10.1093/emboj/cdg209 (Pubitemid 36565521)
27. A Zolkiewska 2005 Ecto-ADP-ribose transferases: cell-surface response to local tissue injury Physiology (Bethesda) 20 374 381 10.1152/physiol.00028.2005 (Pubitemid 41812420)
28. F Di Virgilio P Chiozzi D Ferrari S Falzoni JM Sanz A Morelli M Torboli G Bolognesi OR Baricordi 2001 Nucleotide receptors: an emerging family of regulatory molecules in blood cells Blood 97 3 587 600 10.1182/blood.V97.3.587 (Pubitemid 32113390)
29. F Koch-Nolte J Reyelt B Schössow N Schwarz F Scheuplein S Rothenburg F Haag V Alzogaray A Cauerhff FA Goldbaum 2007 Single domain antibodies from llama effectively and specifically block T cell ecto-ADP-ribosyltransferase ART2.2 in vivo FASEB J 21 13 3490 3498 10.1096/fj.07-8661com (Pubitemid 350075139)
30. S Adriouch S Hubert S Pechberty F Koch-Nolte F Haag M Seman 2007 NAD+ released during inflammation participates in T cell homeostasis by inducing ART2-mediated death of naive T cells in vivo J Immunol 179 1 186 194
31. F Koch-Nolte S Adriouch P Bannas C Krebs F Scheuplein M Seman F Haag 2006 ADP-ribosylation of membrane proteins: unveiling the secrets of a crucial regulatory mechanism in mammalian cells Ann Med 38 3 188 199 10.1080/07853890600655499 (Pubitemid 43675584)
32. F Scheuplein N Schwarz S Adriouch C Krebs P Bannas B Rissiek M Seman F Haag F Koch-Nolte 2009 NAD+ and ATP released from injured cells induce P2X7-dependent shedding of CD62L and externalization of phosphatidylserine by murine T cells J Immunol 182 5 2898 2908 10.4049/jimmunol.0801711
33. S Adriouch P Bannas N Schwarz R Fliegert AH Guse M Seman F Haag F Koch-Nolte 2008 ADP-ribosylation at R125 gates the P2X7 ion channel by presenting a covalent ligand to its nucleotide binding site FASEB J 22 3 861 869 10.1096/fj.07-9294com (Pubitemid 351348137)
34. M Seman S Adriouch F Scheuplein C Krebs D Freese G Glowacki P Deterre F Haag F Koch-Nolte 2003 NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor Immunity 19 4 571 582 10.1016/S1074-7613(03)00266-8 (Pubitemid 37311438)
35. V Ghetie S Popov J Borvak C Radu D Matesoi C Medesan RJ Ober ES Ward 1997 Increasing the serum persistence of an IgG fragment by random mutagenesis Nat Biotechnol 15 7 637 640 10.1038/nbt0797-637
36. G Behar S Sibéril A Groulet P Chames M Pugnière C Boix C Sautès-Fridman JL Teillaud D Baty 2008 Isolation and characterization of anti-FcgammaRIII (CD16) llama single-domain antibodies that activate natural killer cells Protein Eng Des Sel 21 1 1 10 10.1093/protein/gzm064
37. AJ Groot ME Khattabi N Sachs P van der Groep E van der Wall PJ van Diest A Sonnenberg CT Verrips M Vooijs 2009 Reverse proteomic antibody screening identifies anti adhesive VHH targeting VLA-3 Mol Immunol 46 10 2022 2028
38. A Muruganandam J Tanha S Narang D Stanimirovic 2002 Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium FASEB J 16 2 240 242
39. A Abulrob H Sprong P Van Bergen en Henegouwen D Stanimirovic 2005 The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells J Neurochem 95 4 1201 1214 10.1111/j.1471-4159.2005.03463.x (Pubitemid 41713502)
40. V Cortez-Retamozo N Backmann PD Senter U Wernery P De Baetselier S Muyldermans H Revets 2004 Efficient cancer therapy with a nanobody-based conjugate Cancer Res 64 8 2853 2857 10.1158/0008-5472.CAN-03-3935 (Pubitemid 38500625)
41. K Omidfar MJ Rasaee H Modjtahedi M Forouzandeh M Taghikhani N Golmakani 2004 Production of a novel camel single-domain antibody specific for the type III mutant EGFR Tumour Biol 25 5-6 296 305 10.1159/000081395 (Pubitemid 40082334)
42. R Roovers T Laeremans L Huang S De Taeye A Verkleij H Revets HJ de Haard PM van Bergen en Henegouwen 2007 Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR nanobodies Cancer Immunol Immunother 56 3 303 317 10.1007/s00262-006-0180-4 (Pubitemid 46035901)
43. L Huang LO Gainkam V Caveliers C Vanhove M Keyaerts P De Baetselier A Bossuyt H Revets T Lahoutte 2008 SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression Mol Imaging Biol 10 3 167 175
44. BM Tijink T Laeremans M Budde M Stigter-van Walsum T Dreier HJ de Haard CR Leemans GA van Dongen 2008 Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology Mol Cancer Ther 7 8 2288 2297 10.1158/1535-7163.MCT-07-2384
45. F Rahbarizadeh MJ Rasaee M Forouzandeh A Allameh R Sarrami H Nasiry M Sadeghizadeh 2005 The production and characterization of novel heavy-chain antibodies against the tandem repeat region of MUC1 mucin Immunol Invest 34 4 431 452 10.1080/08820130500265356 (Pubitemid 41572137)
46. D Ahmadvand MJ Rasaee F Rahbarizadeh M Mohammadi 2008 Production and characterization of a high-affinity nanobody against human endoglin Hybridoma (Larchmt) 27 5 353 360 10.1089/hyb.2008.0014
47. MA Palladino FR Bahjat EA Theodorakis LL Moldawer 2003 Anti-TNF-alpha therapies: the next generation Nat Rev Drug Discov 2 9 736 746 10.1038/nrd1175
48. DR Maass J Sepulveda A Pernthaner CB Shoemaker 2007 Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs) J Immunol Methods 324 1-2 13 25 10.1016/j.jim.2007.04.008 (Pubitemid 47001424)
49. W Wolfson 2006 Ablynx makes nanobodies from llama bodies Chem Biol 13 12 1243 1244 10.1016/j.chembiol.2006.12.003 (Pubitemid 44918391)
50. JJ Hulstein PG de Groot K Silence A Veyradier R Fijnheer PJ Lenting 2005 A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B Blood 106 9 3035 3042 10.1182/blood-2005-03-1153 (Pubitemid 41565896)
51. D Schenk 2002 Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning Nat Rev Neurosci 3 10 824 828 10.1038/nrn938 (Pubitemid 135706694)
52. M Dumoulin K Conrath A Van Meirhaeghe F Meersman K Heremans LG Frenken S Muyldermans L Wyns A Matagne 2002 Single-domain antibody fragments with high conformational stability Protein Sci 11 3 500 515 10.1110/ps.34602 (Pubitemid 34171255)
53. P Lafaye I Achour P England C Duyckaerts F Rougeon 2009 Single-domain antibodies recognize selectively small oligomeric forms of amyloid beta, prevent Abeta-induced neurotoxicity and inhibit fibril formation Mol Immunol 46 4 695 704 10.1016/j.molimm.2008.09.008
54. G Habicht C Haupt RP Friedrich P Hortschansky C Sachse J Meinhardt K Wieligmann GP Gellermann M Brodhun J Götz KJ Halbhuber C Röcken U Horn M Fändrich 2007 Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils Proc Natl Acad Sci USA 104 49 19232 19237 10.1073/pnas.0703793104
55. R Klooster BT Maassen JC Stam PW Hermans MR Ten Haaft FJ Detmers HJ de Haard JA Post C Theo Verrips 2007 Improved anti-IgG and HSA affinity ligands: clinical application of VHH antibody technology J Immunol Methods 324 1-2 1 12 10.1016/j.jim.2007.04.005 (Pubitemid 47001423)
56. C Cohen-Saidon H Nechushtan S Kahlon N Livni A Nissim E Razin 2003 A novel strategy using single-chain antibody to show the importance of Bcl-2 in mast cell survival Blood 102 7 2506 2512 10.1182/blood-2002-12-3921 (Pubitemid 37193589)
57. C Avignolo L Bagnasco B Biasotti A Melchiori V Tomati I Bauer A Salis L Chiossone MC Mingari P Orecchia B Carnemolla D Neri L Zardi S Parodi 2008 Internalization via Antennapedia protein transduction domain of an scFv antibody toward c-Myc protein FASEB J 22 4 1237 1245 10.1096/fj.07-8865com
58. AJ Groot P Verheesen EJ Westerlaken EH Gort P van der Groep N Bovenschen E van der Wall PJ van Diest A Shvarts 2006 Identification by phage display of single-domain antibody fragments specific for the ODD domain in hypoxia-inducible factor 1alpha Lab Invest 86 4 345 356 10.1038/labinvest. 3700395
59. AJ Groot EH Gort E van der Wall PJ van Diest M Vooijs 2008 Conditional inactivation of HIF-1 using intrabodies Cell Oncol 30 5 397 409
60. P Verheesen A de Kluijver S van Koningsbruggen M de Brij HJ de Haard GJ van Ommen SM van der Maarel CT Verrips 2006 Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear polyA-binding protein with a single-domain intracellular antibody Hum Mol Genet 15 1 105 111 10.1093/hmg/ddi432 (Pubitemid 43020109)
61. D Laune F Molina G Ferrieres JC Mani P Cohen D Simon T Bernardi M Piechaczyk B Pau C Granier 1997 Systematic exploration of the antigen binding activity of synthetic peptides isolated from the variable regions of immunoglobulins J Biol Chem 272 49 30937 30944 10.1074/jbc.272.49.30937 (Pubitemid 27527537)
62. A Marquardt S Muyldermans M Przybylski 2006 A synthetic camel anti-lysozyme peptide antibody (peptibody) with flexible loop structure identified by high-resolution affinity mass spectrometry Chem Eur J 12 7 1915 1923 10.1002/chem.200500785 (Pubitemid 43305281)
63. DA Laplagne V Zylberman N Ainciart MW Steward E Sciutto CA Fossati FA Goldbaum 2004 Engineering of a polymeric bacterial protein as a scaffold for the multiple display of peptides Proteins 57 4 820 828 10.1002/prot.20248 (Pubitemid 39627004)
64. LM Zarebski M Urrutia FA Goldbaum 2005 Llama single domain antibodies as a tool for molecular mimicry J Mol Biol 349 4 814 824 10.1016/j.jmb.2005.03.072 (Pubitemid 40725956)
65. DP Simmons VA Streltsov O Dolezal PJ Hudson AM Coley M Foley DF Proll SD Nuttall 2008 Shark IgNAR antibody mimotopes target a murine immunoglobulin through extended CDR3 loop structures Proteins 71 1 119 130 10.1002/prot.21663 (Pubitemid 351358596)
66. T Gura 2002 Therapeutic antibodies: magic bullets hit the target Nature 417 6889 584 586 10.1038/417584a (Pubitemid 34614794)
67. K Strebhardt A Ullrich 2008 Paul Ehrlich's magic bullet concept: 100 years of progress Nat Rev Cancer 8 6 473 480 10.1038/nrc2394 (Pubitemid 351752547)
68. Aktories K, Just I (2000) Bacterial protein toxins. Springer Verlag, Berlin
69. ER Goldman GP Anderson JL Liu JB Delehanty LJ Sherwood LE Osborn LB Cummins A Hayhurst 2006 Facile generation of heat-stable antiviral and antitoxin single domain antibodies from a semisynthetic llama library Anal Chem 78 24 8245 8255 10.1021/ac0610053 (Pubitemid 44927600)
70. JL Liu GP Anderson JB Delehanty R Baumann A Hayhurst ER Goldman 2007 Selection of cholera toxin specific IgNAR single-domain antibodies from a naïve shark library Mol Immunol 44 7 1775 1783 10.1016/j.molimm.2006.07.299 (Pubitemid 44803164)
71. ER Goldman GP Anderson J Conway LJ Sherwood M Fech B Vo JL Liu A Hayhurst 2008 Thermostable llama single domain antibodies for detection of botulinum A neurotoxin complex Anal Chem 80 22 8583 8591 10.1021/ac8014774
72. M El Khattabi H Adams E Heezius P Hermans F Detmers B Maassen P van der Ley J Tommassen T Verrips J Stam 2006 Llama single-chain antibody that blocks lipopolysaccharide binding and signaling: prospects for therapeutic applications Clin Vaccine Immunol 13 10 1079 1086 10.1128/CVI.00107-06 (Pubitemid 44622533)
73. RA Harrison U Wernery 2007 The unique properties of camelid IgG have potential to improve the treatment of snake bite J Camel Pract Res 14 1 15 16
74. F Meddeb-Mouelhi B Bouhaouala-Zahar Z Benlasfar M Hammadi T Mejri M Moslah H Karoui T Khorchani M El Ayeb 2003 Immunized camel sera and derived immunoglobulin subclasses neutralizing Androctonus australis hector scorpion toxins Toxicon 42 7 785 791 10.1016/j.toxicon.2003.10.021 (Pubitemid 38125038)
75. RA Harrison SS Hasson M Harmsen GD Laing K Conrath RD Theakston 2006 Neutralisation of venom-induced haemorrhage by IgG from camels and llamas immunised with viper venom and also by endogenous, non-IgG components in camelid sera Toxicon 47 3 364 368 10.1016/j.toxicon.2005.10.017 (Pubitemid 43294466)
76. CS Stewart CR MacKenzie JC Hall 2007 Isolation, characterization and pentamerization of alpha-cobrotoxin specific single-domain antibodies from a naïve phage display library: preliminary findings for antivenom development Toxicon 49 5 699 709 10.1016/j.toxicon.2006.11.023 (Pubitemid 46441367)
77. I Hmila RBA Abdallah D Saerens Z Benlasfar K Conrath ME Ayeb S Muyldermans B Bouhaouala-Zahar 2008 VHH, bivalent domains and chimeric heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI Mol Immunol 45 14 3847 3856 10.1016/j.molimm.2008.04.011
78. PJ Doyle M Arbabi-Ghahroudi N Gaudette G Furzer ME Savard S Gleddie MD McLean CR MacKenzie JC Hall 2008 Cloning, expression, and characterization of a single-domain antibody fragment with affinity for 15-acetyl-deoxynivalenol Mol Immunol 45 14 3703 3713 10.1016/j.molimm.2008.06.005
79. S Spinelli LG Frenken P Hermans T Verrips K Brown M Tegoni C Cambillau 2000 Camelid heavy-chain variable domains provide efficient combining sites to haptens Biochemistry 39 6 1217 1222 10.1021/bi991830w (Pubitemid 30090687)
80. RC Ladenson DL Crimmins Y Landt JH Ladenson 2006 Isolation and characterization of a thermally stable recombinant anti-caffeine heavy-chain antibody fragment Anal Chem 78 13 4501 4508 10.1021/ac058044j
81. GP Anderson ER Goldman 2008 TNT detection using llama antibodies and a two-step competitive fluid array immunoassay J Immunol Methods 339 1 47 54 10.1016/j.jim.2008.08.001
82. N Alvarez-Rueda G Behar V Ferré M Pugnière F Roquet L Gastinel C Jacquot J Aubry D Baty J Barbet S Birklé 2007 Generation of llama single-domain antibodies against methotrexate, a prototypical hapten Mol Immunol 44 7 1680 1690 10.1016/j.molimm.2006.08.007
83. DM Goldenberg RM Sharkey G Paganelli J Barbet JF Chatal 2006 Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy J Clin Oncol 24 5 823 834 10.1200/JCO.2005.03.8471 (Pubitemid 46671186)
84. A Forsman E Beirnaert MM Aasa-Chapman B Hoorelbeke K Hijazi W Koh V Tack A Szynol C Kelly A McKnight T Verrips H De Haard RA Weiss 2008 Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120 J Virol 82 24 12069 12081 10.1128/JVI.01379-08
85. L Garaicoechea A Olichon G Marcoppido A Wigdorovitz M Mozgovoj L Saif T Surrey V Parreño 2008 Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice J Virol 82 19 9753 9764 10.1128/JVI.00436-08
86. MM Harmsen CB van Solt HP Fijten L van Keulen RA Rosalia K Weerdmeester AH Cornelissen MG De Bruin PL Eble A Dekker 2007 Passive immunization of guinea pigs with llama single-domain antibody fragments against foot-and-mouth disease Vet Microbiol 120 3-4 193 206 10.1016/j.vetmic.2006.10.029 (Pubitemid 46216650)
87. MM Harmsen HP Fijten A Dekker PL Eblé 2008 Passive immunization of pigs with bispecific llama single-domain antibody fragments against foot-and-mouth disease and porcine immunoglobulin Vet Microbiol 132 1-2 56 64 10.1016/j.vetmic.2008.04.030
88. A Hultberg D Tremblay H De Haard T Verrips S Moineau L Hammarström H Marcotte 2007 Lactobacilli expressing llama VHH fragments neutralise Lactococcus phages BMC Biotechnol 7 58 10.1186/1472-6750-7-58 (Pubitemid 47618104)
89. HJ de Haard S Bezemer AM Ledeboer WH Müller PJ Boender S Moineau MC Coppelmans A Verkleij LG Frenken CT Verrips 2005 Llama antibodies against a lactococcal protein located at the tip of the phage tail prevent phage infection J Bacteriol 187 13 4531 4541 10.1128/JB.187.13.4531-4541.2005 (Pubitemid 40880965)
90. AM Ledeboer S Bezemer JJ de Hiaard IM Schaffers CT Verrips C van Vliet EM Düsterhöft P Zoon S Moineau LG Frenken 2002 Preventing phage lysis of Lactococcus lactis in cheese production using a neutralizing heavy-chain antibody fragment from llama J Dairy Sci 85 6 1376 1382
91. S Dekker W Toussaint G Panayotou T de Wit P Visser F Grosveld D Drabek 2003 Intracellularly expressed single-domain antibody against p15 matrix protein prevents the production of porcine retroviruses J Virol 77 22 12132 12139 10.1128/JVI.77.22.12132-12139.2003 (Pubitemid 37339866)
92. LJ Sherwood LE Osborn R Carrion JL Patterson A Hayhurst 2007 Rapid assembly of sensitive antigen-capture assays for Marburg virus, using in vitro selection of llama single-domain antibodies, at biosafety level 4 J Infect Dis 196 Suppl 2 S213 S219 10.1086/520586
93. MM Harmsen CB van Solt AM van Zijderveld-van Bemmel TA Niewold FG van Zijderveld 2006 Selection and optimization of proteolytically stable llama single-domain antibody fragments for oral immunotherapy Appl Microbiol Biotechnol 72 3 544 551 10.1007/s00253-005-0300-7 (Pubitemid 44273082)
94. A Szynol JJ de Soet E Sieben-van Tuyl JW Bos LG Frenken 2004 Bactericidal effects of a fusion protein of llama heavy-chain antibodies coupled to glucose oxidase on oral bacteria Antimicrob Agents Chemother 48 9 3390 3395 10.1128/AAC.48.9.3390-3395.2004 (Pubitemid 39129335)
95. C Krüger A Hultberg H Marcotte P Hermans S Bezemer LG Frenken L Hammarström 2006 Therapeutic effect of llama derived VHH fragments against Streptococcus mutans on the development of dental caries Appl Microbiol Biotechnol 72 4 732 737 10.1007/s00253-006-0347-0 (Pubitemid 44454934)
96. KV Korotkov E Pardon J Steyaert WG Hol 2009 Crystal structure of the N-terminal domain of the secretin GspD from ETEC determined with the assistance of a nanobody Structure 17 2 255 265 10.1016/j.str.2008.11.011
97. AY Lam E Pardon KV Korotkov WG Hol J Steyaert 2009 Nanobody-aided structure determination of the EpsI:EpsJ pseudopilin heterodimer from Vibrio vulnificus J Struct Biol 166 1 8 15 10.1016/j.jsb.2008.11.008
98. S Spinelli A Desmyter CT Verrips HJ de Haard S Moineau C Cambillau 2006 Lactococcal bacteriophage p2 receptor-binding protein structure suggests a common ancestor gene with bacterial and mammalian viruses Nat Struct Mol Biol 13 1 85 89 10.1038/nsmb1029 (Pubitemid 43049407)
99. KE Conrath M Lauwereys M Galleni A Matagne JM Frère J Kinne L Wyns S Muyldermans 2001 Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae Antimicrob Agents Chemother 45 10 2807 2812 10.1128/AAC.45.10.2807-2812.2001 (Pubitemid 32906675)
100. B Stijlemans K Conrath V Cortez-Retamozo H Van Xong L Wyns P Senter H Revets P De Baetselier S Muyldermans S Magez 2004 Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm J Biol Chem 279 2 1256 1261 10.1074/jbc.M307341200 (Pubitemid 38082649)
101. TN Baral S Magez B Stijlemans K Conrath B Vanhollebeke E Pays S Muyldermans P De Baetselier 2006 Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor Nat Med 12 5 580 584 10.1038/nm1395
102. D Saerens B Stijlemans T Baral GT Nguyen Thi U Wernery S Magez P De Baetselier S Muyldermans K Conrath 2008 Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens J Immunol Methods 329 1-2 138 150 10.1016/j.jim.2007.10.005 (Pubitemid 350235467)
103. L Ratier M Urrutia G Paris L Zarebski AC Frasch FA Goldbaum 2008 Relevance of the diversity among members of the Trypanosoma cruzi trans-sialidase family analyzed with camelids single-domain antibodies PLoS One 3 10 e3524 10.1371/journal.pone.0003524
104. N Deckers D Saerens K Kanobana K Conrath B Victor U Wernery J Vercruysse S Muyldermans P Dorny 2009 Nanobodies, a promising tool for species-specific diagnosis of Taenia solium cysticercosis Int J Parasitol 39 5 625 633 10.1016/j.ijpara.2008.10.012
105. E Dolk M van der Vaart D Lutje Hulsik G Vriend H De Haard S Spinelli C Cambillau L Frenken T Verrips 2005 Isolation of llama antibody fragments for prevention of dandruff by phage display in shampoo Appl Environ Microbiol 71 1 442 450 10.1128/AEM.71.1.442-450.2005 (Pubitemid 40116300)
106. AS Greenberg D Avila M Hughes A Hughes EC McKinney MF Flajnik 1995 A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks Nature 374 6518 168 173 10.1038/374168a0
107. C Vincke R Loris D Saerens S Martinez-Rodriguez S Muyldermans K Conrath 2009 General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold J Biol Chem 284 5 3273 3284 10.1074/jbc.M806889200
108. X Zou JA Smith VK Nguyen L Ren K Luyten S Muyldermans M Bruggemann 2005 Expression of a dromedary heavy chain-only antibody and B cell development in the mouse J Immunol 175 6 3769 3779
109. R Janssens S Dekker RW Hendriks G Panayotou A van Remoortere JK San F Grosveld D Drabek 2006 Generation of heavy-chain-only antibodies in mice Proc Natl Acad Sci USA 103 41 15130 15135 10.1073/pnas.0601108103 (Pubitemid 44583176)
110. EG Hofman MO Ruonala AN Bader D van den Heuvel J Voortman R Roovers A Verkleij HC Gerritsen PM van Bergen en Henegouwen 2008 EGF induces coalescence of different lipid rafts J Cell Sci 121 Pt 15 2519 2528 10.1242/jcs.028753
111. LO Gainkam L Huang V Caveliers M Keyaerts S Hernot I Vaneycken C Vanhove H Revets P De Baetselier T Lahoutte 2008 Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT J Nucl Med 49 5 788 795 10.2967/jnumed.107.048538 (Pubitemid 351717545)
112. F Rahbarizadeh MJ Rasaee M Forouzandeh AA Allameh 2006 Over expression of anti-MUC1 single-domain antibody fragments in the yeast Pichia pastoris Mol Immunol 43 5 426 435 10.1016/j.molimm.2005.03.003 (Pubitemid 41740431)
113. S Winichayakul A Pernthaner R Scott R Vlaming N Roberts 2008 Head-to-tail fusions of camelid antibodies can be expressed in planta and bind in rumen fluid Biotechnol Appl Biochem 53 Pt 2 111 122
114. D Saerens F Frederix G Reekmans K Conrath K Jans L Brys L Huang E Bosmans G Maes G Borghs S Muyldermans 2005 Engineering camel single-domain antibodies and immobilization chemistry for human prostate-specific antigen sensing Anal Chem 77 23 7547 7555 10.1021/ac051092j (Pubitemid 41746221)
115. D Saerens J Kinne E Bosmans U Wernery S Muyldermans K Conrath 2004 Single domain antibodies derived from dromedary lymph node and peripheral blood lymphocytes sensing conformational variants of prostate-specific antigen J Biol Chem 279 50 51965 51972 10.1074/jbc.M409292200 (Pubitemid 39656566)
116. PH Chan E Pardon L Menzer E De Genst JR Kumita J Christodoulou D Saerens A Brans F Bouillenne DB Archer CV Robinson S Muyldermans A Matagne C Redfield L Wyns CM Dobson M Dumoulin 2008 Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils Biochemistry 47 42 11041 11054 10.1021/bi8005797
117. A Chartier V Raz E Sterrenburg CT Verrips SM van der Maarel M Simonelig 2009 Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo Hum Mol Genet 18 10 1849 1859 10.1093/hmg/ddp101
118. S van Koningsbruggen H De Haard P de Kievit RW Dirks A van Remoortere AJ Groot BG van Engelen JT den Dunnen CT Verrips RR Frants SM van der Maarel 2003 Llama-derived phage display antibodies in the dissection of the human disease oculopharyngeal muscular dystrophy J Immunol Methods 279 1-2 149 161 10.1016/S0022-1759(03)00232-1 (Pubitemid 37297499)
119. JL Liu GP Anderson ER Goldman 2007 Isolation of anti-toxin single domain antibodies from a semi-synthetic spiny dogfish shark display library BMC Biotechnol 7 78 10.1186/1472-6750-7-78 (Pubitemid 351167776)
120. JM van der Vaart N Pant D Wolvers S Bezemer PW Hermans K Bellamy SA Sarker CP van der Logt L Svensson CT Verrips L Hammarstrom BJ van Klinken 2006 Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments Vaccine 24 19 4130 4137 10.1016/j.vaccine.2006.02.045 (Pubitemid 44308223)
121. MM Harmsen CB van Solt A Hoogendoorn FG van Zijderveld TA Niewold J van der Meulen 2005 Escherichia coli F4 fimbriae specific llama single-domain antibody fragments effectively inhibit bacterial adhesion in vitro but poorly protect against diarrhoea Vet Microbiol 111 1-2 89 98 10.1016/j.vetmic.2005.09. 005 (Pubitemid 41578945)
122. KA Henderson V Streltsov A Coley O Dolezal PJ Hudson AH Batchelor A Gupta T Bai VJ Murphy RF Anders M Foley S Nuttall 2007 Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition Structure 15 11 1452 1466 10.1016/j.str.2007.09.011 (Pubitemid 350051923)
123. DeLano W (2002) The PyMOL user's manual. DeLano Scientific, San Carlos, CA
124. RL Stanfield H Dooley MF Flajnik IA Wilson 2004 Crystal structure of a shark single-domain antibody V region in complex with lysozyme Science 305 5691 1770 1773 10.1126/science.1101148 (Pubitemid 39249643)
125. AT Hadfield DJ Harvey DB Archer DA MacKenzie DJ Jeenes SE Radford G Lowe CM Dobson LN Johnson 1994 Crystal structure of the mutant D52S hen egg white lysozyme with an oligosaccharide product J Mol Biol 243 5 856 872 10.1006/jmbi.1994.1688 (Pubitemid 24348854)
126. BC Braden H Souchon JL Eisele GA Bentley TN Bhat J Navaza RJ Poljak 1994 Three-dimensional structures of the free and the antigen-complexed Fab from monoclonal anti-lysozyme antibody D44.1 J Mol Biol 243 4 767 781 10.1016/0022-2836(94)90046-9 (Pubitemid 24341717)
127. MR Bazl MJ Rasaee M Foruzandeh A Rahimpour J Kiani F Rahbarizadeh B Alirezapour M Mohammadi 2007 Production of chimeric recombinant single domain antibody-green fluorescent fusion protein in Chinese hamster ovary cells Hybridoma (Larchmt) 26 1 1 9 10.1089/hyb.2006.037 (Pubitemid 46294367)
128. U Rothbauer K Zolghadr S Muyldermans A Schepers MC Cardoso H Leonhardt 2008 A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins Mol Cell Proteomics 7 2 282 289 10.1074/mcp.M700342- MCP200 (Pubitemid 351298442)